Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Am J Respir Crit Care Med

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    June 2022
  1. MARAIS BJ, Graham SM
    The Value of Chest Radiography in Tuberculosis Preventive Treatment (TPT) Screening in Children and Adolescents.
    Am J Respir Crit Care Med. 2022 Jun 2. doi: 10.1164/rccm.202205-1023.
    PubMed    


    May 2022
  2. DOWDY DW
    Coughing is Not Required to Transmit Mycobacterium tuberculosis: Another Nail in the Coffin.
    Am J Respir Crit Care Med. 2022 May 25. doi: 10.1164/rccm.202204-0645.
    PubMed    


  3. HUANG CC, Tan Q, Becerra MC, Calderon R, et al
    The Contribution of Chest Radiography to the Clinical Management of Children Exposed to Tuberculosis.
    Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202202-0259.
    PubMed     Abstract available


  4. DINKELE R, Gessner S, McKerry A, Leonard B, et al
    Aerosolization of Mycobacterium tuberculosis by Tidal Breathing.
    Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202110-2378.
    PubMed     Abstract available


  5. TOBIN MJ
    Fiftieth Anniversary of Uncovering the Tuskegee Syphilis Study: The Story and Timeless Lessons.
    Am J Respir Crit Care Med. 2022;205:1145-1158.
    PubMed     Abstract available


  6. DE JAGER V, Gupte N, Nunes S, Barnes GL, et al
    Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.
    Am J Respir Crit Care Med. 2022;205:1228-1235.
    PubMed     Abstract available


  7. ESMAIL A, Oelofse S, Lombard C, Perumal R, et al
    An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
    Am J Respir Crit Care Med. 2022;205:1214-1227.
    PubMed     Abstract available


  8. OLIVIER KN, Prevots DR
    HALTing Nontuberculous Mycobacteria in Cystic Fibrosis Centers: Is There Something in the Water?
    Am J Respir Crit Care Med. 2022;205:982-983.
    PubMed    


  9. GROSS JE, Caceres S, Poch K, Hasan NA, et al
    Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program.
    Am J Respir Crit Care Med. 2022;205:1064-1074.
    PubMed     Abstract available


    April 2022
  10. SHAKU MT, Bishai WR
    Mycobacterium tuberculosis: A Pathogen That Can Hold its Breath a Long Time.
    Am J Respir Crit Care Med. 2022 Apr 20. doi: 10.1164/rccm.202203-0432.
    PubMed    


  11. BUCSAN AN, Veatch A, Singh DK, Akter S, et al
    Response to Hypoxia and the Ensuing Dysregulation of Inflammation Impacts Mycobacterium tuberculosis Pathogenicity.
    Am J Respir Crit Care Med. 2022 Apr 12. doi: 10.1164/rccm.202112-2747.
    PubMed     Abstract available


  12. PITTET LF, Fritschi N, Tebruegge M, Dutta B, et al
    Bacillus Calmette-Guerin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.
    Am J Respir Crit Care Med. 2022;205:830-841.
    PubMed     Abstract available


    March 2022
  13. LANGE C, Barry Iii CE, Horsburgh CR Jr
    Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the Tunnel.
    Am J Respir Crit Care Med. 2022 Mar 23. doi: 10.1164/rccm.202202-0393.
    PubMed    


    February 2022
  14. COOKSON W, Moffatt M, Rapeport G, Quint J, et al
    A Pandemic Lesson for Global Lung Diseases: Exacerbations are Preventable.
    Am J Respir Crit Care Med. 2022 Feb 22. doi: 10.1164/rccm.202110-2389.
    PubMed     Abstract available


    January 2022
  15. SCHLUGER NW
    Of Mice and Men, Women, and Children: Using Animal Models to Inform Tuberculosis Clinical Trials of Novel Agents.
    Am J Respir Crit Care Med. 2022 Jan 31. doi: 10.1164/rccm.202112-2866.
    PubMed    


  16. CHO HJ, Yu JH
    Quincke's Sign of Janeway Lesion in Infective Endocarditis.
    Am J Respir Crit Care Med. 2022 Jan 27. doi: 10.1164/rccm.202110-2362.
    PubMed    


  17. O'DONNELL M, Mathema B
    Expanding the Tuberculosis Cascade of Care to Treat Undiagnosed and Subclinical Tuberculosis in High-Burden Settings.
    Am J Respir Crit Care Med. 2022;205:149-151.
    PubMed    


    December 2021
  18. KAUSHIK A, Ammerman NC, Tasneen R, Lachau-Durand S, et al
    Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.
    Am J Respir Crit Care Med. 2021 Dec 23. doi: 10.1164/rccm.202012-4541.
    PubMed     Abstract available


  19. FENNELLY KP, Martinez L, Mandalakas AM
    Tuberculosis: First in Flight.
    Am J Respir Crit Care Med. 2021 Dec 14. doi: 10.1164/rccm.202111-2513.
    PubMed    


  20. SHIMIZU T, Watanabe S, Murata A, Kasahara K, et al
    Bronchial Cast Hiding Pulmonary Tuberculosis.
    Am J Respir Crit Care Med. 2021 Dec 3. doi: 10.1164/rccm.202105-1306.
    PubMed    


  21. SCHLUGER NW
    Using Isoniazid More Safely and More Effectively: The Time Is Now.
    Am J Respir Crit Care Med. 2021;204:1248-1250.
    PubMed    


  22. WATERS V
    Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations.
    Am J Respir Crit Care Med. 2021;204:1245-1247.
    PubMed    


    November 2021
  23. BUNYASI EW, Middelkoop K, Koch A, Hoosen Z, et al
    Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools.
    Am J Respir Crit Care Med. 2021 Nov 9. doi: 10.1164/rccm.202102-0405.
    PubMed     Abstract available


  24. ADJOBIMEY M, Behr MA, Menzies D
    Individualized Treatment Duration in Tuberculosis Treatment: Precision versus Simplicity.
    Am J Respir Crit Care Med. 2021;204:1013-1014.
    PubMed    


    October 2021
  25. ATRE SR, Jagtap JD, Faqih MI, Dumbare YK, et al
    Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202012-4333.
    PubMed     Abstract available


  26. NOURSADEGHI M, Gupta RK
    New Insights into the Limitations of Host-Transcriptional Biomarkers of Tuberculosis.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202109-2146.
    PubMed    


    September 2021
  27. LU S, Kolls JK
    Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model.
    Am J Respir Crit Care Med. 2021;204:626-627.
    PubMed    


  28. MULENGA H, Musvosvi M, Mendelsohn SC, Penn-Nicholson A, et al
    Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis.
    Am J Respir Crit Care Med. 2021 Sep 14. doi: 10.1164/rccm.202103-0548.
    PubMed     Abstract available


  29. DARTOIS V, Dick T
    A Ginger Root or Plum Model for the Tuberculosis "Granuloma"?
    Am J Respir Crit Care Med. 2021;204:505-507.
    PubMed    


    August 2021
  30. DAVIS JL, Checkley W
    Characterization of Air Pollution Exposures as Risk Factors for Tuberculosis Infection.
    Am J Respir Crit Care Med. 2021 Aug 30. doi: 10.1164/rccm.202107-1795.
    PubMed    


  31. GAUSI K, Ignatius EH, Sun X, Kim S, et al
    A Semi-Mechanistic Model of the Bactericidal Activity of High-Dose Isoniazid Against Multi-Drug-Resistant Tuberculosis: Results from a Randomized Clinical Trial.
    Am J Respir Crit Care Med. 2021 Aug 17. doi: 10.1164/rccm.202103-0534.
    PubMed     Abstract available


  32. MITNICK CD, Furin JJ, Hewison C
    The Reductionist Conundrum of an "Updated" Definition of Extensively Drug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2021 Aug 10. doi: 10.1164/rccm.202106-1516.
    PubMed    


  33. VERMA R, Patil S, Zhang N, Moreira FMF, et al
    A Rapid Pharmacogenomic Assay to Detect NAT2 Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment.
    Am J Respir Crit Care Med. 2021 Aug 10. doi: 10.1164/rccm.202103-0564.
    PubMed     Abstract available


  34. IMPERIAL MZ, Phillips PPJ, Nahid P, Savic RM, et al
    Precision-enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials.
    Am J Respir Crit Care Med. 2021 Aug 4. doi: 10.1164/rccm.202101-0117.
    PubMed     Abstract available


  35. BLOUNT RJ, Phan H, Trinh T, Dang H, et al
    Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children.
    Am J Respir Crit Care Med. 2021 Aug 3. doi: 10.1164/rccm.202101-0136.
    PubMed     Abstract available


  36. MEKEIRELE M, Broeckhoven V, Wilmer A, Balthazar T, et al
    Interpreting the Deep Sulcus Sign.
    Am J Respir Crit Care Med. 2021;204:357-358.
    PubMed    


    July 2021
  37. KATAYAMA S, Tonai K, Minakata D, Nunomiya S, et al
    Pseudomembranous Invasive Tracheobronchial Aspergillosis.
    Am J Respir Crit Care Med. 2021 Jul 8. doi: 10.1164/rccm.202009-3659.
    PubMed    


    June 2021
  38. XIE P, Liu J, Wu L, Liu D, et al
    Pulmonary Cavitation: A Hint of Ralstonia mannitolilytica Infection through Imaging.
    Am J Respir Crit Care Med. 2021;203:1569-1570.
    PubMed    


  39. ROELENS M, Battista Migliori G, Rozanova L, Estill J, et al
    Evidence-based Definition for Extensively Drug-resistant Tuberculosis.
    Am J Respir Crit Care Med. 2021 Jun 9. doi: 10.1164/rccm.202009-3527.
    PubMed     Abstract available


  40. JOHNSON MDL, Younis US, Menghani SV, Addison KJ, et al
    CC16 Binding to alpha4beta1 Integrin Protects against Mycoplasma pneumoniae Infection.
    Am J Respir Crit Care Med. 2021;203:1410-1418.
    PubMed     Abstract available


    May 2021
  41. WELLS G, Glasgow JN, Nargan K, Lumamba K, et al
    microCT Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in 3D Granuloma Morphology.
    Am J Respir Crit Care Med. 2021 May 20. doi: 10.1164/rccm.202101-0032.
    PubMed     Abstract available


  42. LONG DR, Wolter DJ, Lee M, Precit M, et al
    Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis Staphylococcus aureus Airway Infection.
    Am J Respir Crit Care Med. 2021;203:1127-1137.
    PubMed     Abstract available


    April 2021

  43. Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques.
    Am J Respir Crit Care Med. 2021;203:1045.
    PubMed    


  44. HUGHES DA, Price H, Rosenthal M, Davies JC, et al
    Pseudomonas aeruginosa in the Cystic Fibrosis Airway: Does It Deserve Its Reputation as a Predatory "Bully"?
    Am J Respir Crit Care Med. 2021;203:1027-1030.
    PubMed    


  45. HUDDART S, Savic RM, Cattamanchi A
    Is Glycemic Control the Secret to Tuberculosis Control?
    Am J Respir Crit Care Med. 2021 Apr 7. doi: 10.1164/rccm.202103-0703.
    PubMed    


  46. MILLER JO, Shih AR, Mino-Kenudson M, Taylor MS, et al
    Trimethoprim-Sulfamethoxazole-associated Fulminant Respiratory Failure in Children and Young Adults.
    Am J Respir Crit Care Med. 2021;203:918-921.
    PubMed    


    March 2021
  47. BEHR MA, Kaufmann E, Duffin J, Edelstein PH, et al
    Latent Tuberculosis: Two Centuries of Confusion.
    Am J Respir Crit Care Med. 2021 Mar 24. doi: 10.1164/rccm.202011-4239.
    PubMed     Abstract available


  48. LIU Q, You N, Pan H, Shen Y, et al
    Glycemic Trajectories After Tuberculosis Diagnosis and Treatment Outcomes of New Tuberculosis Patients: A Prospective Study in Eastern China.
    Am J Respir Crit Care Med. 2021 Mar 11. doi: 10.1164/rccm.202007-2634.
    PubMed     Abstract available


  49. KENDALL EA, Shrestha S, Dowdy DW
    Reply to: Subclinical Tuberculosis: Some Flies in the Ointment.
    Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202102-0367.
    PubMed    


  50. PIERCE CW
    Subclinical Tuberculosis: Some Flies in the Ointment.
    Am J Respir Crit Care Med. 2021 Mar 9. doi: 10.1164/rccm.202101-0227.
    PubMed    


  51. LE ROUX SP, Upton C, Vanker N, Dooley KE, et al
    Resistance-Conferring Mycobacterial Mutations and Quantification of Early Bactericidal Activity.
    Am J Respir Crit Care Med. 2021;203:635-637.
    PubMed    


  52. IOVINO F, Henriques-Normark B
    Experimental Model for Studies of Pneumococcal Colonization in Older Adults.
    Am J Respir Crit Care Med. 2021;203:539-540.
    PubMed    


  53. JORTH P, Durfey S, Rezayat A, Garudathri J, et al
    Cystic Fibrosis Lung Function Decline after Within-Host Evolution Increases Virulence of Infecting Pseudomonas aeruginosa.
    Am J Respir Crit Care Med. 2021;203:637-640.
    PubMed    


  54. BUETTI N, Mimoz O, Schwebel C, Ruckly S, et al
    Insertion Site and Infection Risk among Peripheral Arterial Catheters.
    Am J Respir Crit Care Med. 2021;203:630-633.
    PubMed    


  55. ADLER H, German EL, Mitsi E, Nikolaou E, et al
    Experimental Human Pneumococcal Colonization in Older Adults Is Feasible and Safe, Not Immunogenic.
    Am J Respir Crit Care Med. 2021;203:604-613.
    PubMed     Abstract available


    February 2021
  56. ESCALANTE P, Wilson JW
    New Diagnostics to Infer Risk in Tuberculosis: Is the Term Latent Tuberculosis Infection Obsolete?
    Am J Respir Crit Care Med. 2021 Feb 17. doi: 10.1164/rccm.202101-0131.
    PubMed    


    January 2021
  57. LOUGHLIN L, McAuley DF, Simpson AJ, McMullan R, et al
    Reply to: Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
    Am J Respir Crit Care Med. 2021 Jan 26. doi: 10.1164/rccm.202101-0026.
    PubMed    


  58. ABEREGG SK, Wolfe BM
    Aspergillosis in the ICU: Hidden Enemy or Bogeyman?
    Am J Respir Crit Care Med. 2021 Jan 26. doi: 10.1164/rccm.202012-4486.
    PubMed    


  59. HAMAD AM, Rea F, Haroon S
    Bronchial Atresia and Bronchogenic Cyst with Saprophytic Aspergilloma.
    Am J Respir Crit Care Med. 2021 Jan 25. doi: 10.1164/rccm.202010-3876.
    PubMed    


  60. AKSAMIT TR
    One Step Closer: Nontuberculous Mycobacterial Pulmonary Disease and Predicted Mortality-The BACES Score.
    Am J Respir Crit Care Med. 2021;203:163-164.
    PubMed    


  61. KIM HJ, Kwak N, Hong H, Kang N, et al
    BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease.
    Am J Respir Crit Care Med. 2021;203:230-236.
    PubMed     Abstract available


  62. HARRISON F, Smyth AR
    Professor Pangloss and the Pangenome: Does Staphylococcus aureus Have the Best of All Possible Worlds?
    Am J Respir Crit Care Med. 2021 Jan 11. doi: 10.1164/rccm.202012-4533.
    PubMed    


  63. MPANDE CAM, Musvosvi M, Rozot V, Mosito B, et al
    Antigen-specific T Cell Activation Distinguishes Between Recent and Remote Tuberculosis Infection.
    Am J Respir Crit Care Med. 2021 Jan 6. doi: 10.1164/rccm.202007-2686.
    PubMed     Abstract available


  64. FRANKE MF, Khan P, Hewison C, Khan U, et al
    Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
    Am J Respir Crit Care Med. 2021;203:111-119.
    PubMed     Abstract available


    December 2020
  65. WAUTERS J, Lamoth F, Rijnders BJ, Calandra T, et al
    Invasive Pulmonary Aspergillosis Goes Viral Again?
    Am J Respir Crit Care Med. 2020 Dec 22. doi: 10.1164/rccm.202012-4413.
    PubMed    


  66. RAMOS-SEVILLANO E, Ercoli G, Felgner P, Ramiro de Assis R, et al
    Preclinical Development of Virulence Attenuated Streptococcus pneumoniae Strains Able to Enhance Protective Immunity Against Pneumococcal Infection.
    Am J Respir Crit Care Med. 2020 Dec 17. doi: 10.1164/rccm.202011-4161.
    PubMed    


  67. FEKKAR A, Lampros A, Mayaux J, Poignon C, et al
    Occurrence of Invasive Pulmonary Fungal Infections in Severe COVID-19 Patients Admitted to the ICU.
    Am J Respir Crit Care Med. 2020 Dec 2. doi: 10.1164/rccm.202009-3400.
    PubMed     Abstract available


  68. HOSODA C, Ishiguro T, Shimizu Y, Kanegane H, et al
    Mycobacterium genavense Infection Presenting as an Endobronchial Polyp and Upper Lobe Atelectasis.
    Am J Respir Crit Care Med. 2020;202:e144-e145.
    PubMed    


    November 2020
  69. KENDALL EA, Shrestha S, Dowdy DW
    The Epidemiological Importance of Subclinical Tuberculosis: A Critical Re-Appraisal.
    Am J Respir Crit Care Med. 2020 Nov 16. doi: 10.1164/rccm.202006-2394.
    PubMed     Abstract available


  70. WU BG, Sulaiman I, Tsay JJ, Perez L, et al
    Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary Th17 Response that Mitigates Susceptibility to Streptococcus pneumoniae.
    Am J Respir Crit Care Med. 2020 Nov 9. doi: 10.1164/rccm.202005-1596.
    PubMed     Abstract available


    October 2020
  71. SI X, Shi J
    Pulmonary and Skeletal Infection of Mycobacterium kansasii.
    Am J Respir Crit Care Med. 2020;202:1169-1170.
    PubMed    


  72. GARDNER AI, Haq IJ, Simpson AJ, Becker KA, et al
    Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1133-1145.
    PubMed     Abstract available


  73. OCAK S, d'Odemont JP
    Cavernoscopic Views of a Pleural Aspergillosis.
    Am J Respir Crit Care Med. 2020 Oct 6. doi: 10.1164/rccm.202004-0927.
    PubMed    


  74. HONDA JR
    Reply to Ward et al.: Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1062.
    PubMed    


  75. WARD C, Al Momani H, Perry A, Perry JD, et al
    Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:1061.
    PubMed    


  76. SHALLER BD, Chen SB, Ho DY, Yu DH, et al
    Atypical Blastomycosis Masquerading as Lofgren Syndrome.
    Am J Respir Crit Care Med. 2020;202:1035-1036.
    PubMed    


    September 2020
  77. BLAIZE M, Mayaux J, Luyt CE, Lampros A, et al
    COVID-19 Related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.
    Am J Respir Crit Care Med. 2020 Sep 17. doi: 10.1164/rccm.202007-2938.
    PubMed    


  78. MENON AA, Berg DD, Gay EB, Fredenburgh LE, et al
    Reply to: COVID-19 Related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis.
    Am J Respir Crit Care Med. 2020 Sep 17. doi: 10.1164/rccm.202008-3174.
    PubMed    


  79. CHANG KC, Yew WW
    ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?
    Am J Respir Crit Care Med. 2020;202:777-778.
    PubMed    


  80. SOTGIU G, Battista Migliori G, Menzies D, Mase S, et al
    Reply to Chang and Yew.
    Am J Respir Crit Care Med. 2020;202:778-779.
    PubMed    


    August 2020
  81. KYRIAZOPOULOU E, Liaskou-Antoniou L, Adamis G, Panagaki A, et al
    Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis: A Randomized Trial.
    Am J Respir Crit Care Med. 2020 Aug 6. doi: 10.1164/rccm.202004-1201.
    PubMed     Abstract available


  82. DAWRS SN, Kautz M, Chan ED, Honda JR, et al
    Mycobacterium abscessus and Gastroesophageal Reflux: An In Vitro Study.
    Am J Respir Crit Care Med. 2020;202:466-469.
    PubMed    


  83. KOHLMAIER B, Strenger V, Egger M, Modl M, et al
    Persistent Stridor in a 10-Year-Old Patient with Cystic Fibrosis.
    Am J Respir Crit Care Med. 2020;202:e72-e73.
    PubMed    


    May 2020
  84. HIBINO M, Horiuchi S, Kondo T
    Localized Tracheal Cryptococcosis Misdiagnosed as Severe Refractory Asthma.
    Am J Respir Crit Care Med. 2020 May 27. doi: 10.1164/rccm.202001-0032.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: